News Announcement

Omkar Pharmachem: Board Meeting Intimation for Board Meeting Intimation For Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Half Yearly Ended September 30 2025

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited Standalone Financial Results Of The Company For The Quarter & Half Yearly Ended September 30 2025.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.